Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
Combinatorial Chemistry & High Throughput Screening|February 22, 2005
1,4-bis(3-aminopropyl)piperazine libraries: from the discovery of classical chloroquine-like antimalarials to the identification of new targetsRébecca Deprez-Poulain, Patricia MelnykExpert Opinion on Therapeutic Patents|June 29, 2022
Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present)Benjamin Zagiel, Patricia Melnyk, Philippe CotelleBioconjugate Chemistry|March 20, 2014
Phenylthiocarbamate or N-carbothiophenyl group chemistry in peptide synthesis and bioconjugationOleg Melnyk, Nathalie Ollivier, Soizic Besret, et al.Bioorganic & Medicinal Chemistry Letters|November 3, 2005
Design, synthesis and in vitro antimalarial activity of an acylhydrazone libraryPatricia Melnyk, Virginie Leroux, Christian Sergheraert, et al.Journal of Medicinal Chemistry|December 19, 2017
Targeting Transcriptional Enhanced Associate Domains (TEADs)Floriane Gibault, Manon Sturbaut, Fabrice Bailly, et al.European Journal of Medicinal Chemistry|May 14, 2011
Buchwald reaction as the key step for the synthesis of metabolically more stable analogs of amodiaquineNicolas Le Fur, Guillaume Hochart, Paul-Emmanuel Larchanché, et al.Journal of Medicinal Chemistry|August 18, 2006
Similar structure-activity relationships of quinoline derivatives for antiprion and antimalarial effectsRalf Klingenstein, Patricia Melnyk, S Rutger Leliveld, et al.Journal of Medicinal Chemistry|February 7, 2020
EGF-Containing Membrane-Bound Mucins: A Hidden ErbB2 Targeting Pathway?Maxime Liberelle, Nicolas Jonckheere, Patricia Melnyk, et al.European Journal of Medicinal Chemistry|January 21, 2015
Synthesis and pharmacological evaluation of benzannulated derivatives as potent and selective sigma-1 protein ligandsMarion Donnier-Maréchal, Pascal Carato, Delphine Le Broc, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|February 9, 2019
(Hetero)aryl substituted thiazol-2,4-yl scaffold as human carbonic anhydrase I, II, VII and XIV activatorsMarouan Rami, Jean-Yves Winum, Claudiu T Supuran, et al.Pageof 8